Anavex Life Sciences Corporation’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $10.45 on 11/11/24, and the lowest price during the same period was recorded at $3.25 on 04/25/24.
52-week price history of AVXL Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Anavex Life Sciences Corporation’s current trading price is -27.27% away from its 52-week high, while its distance from the 52-week low is 133.85%. The stock’s price range for this period has remained between $3.25 and $10.45. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.49 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.09 million over the last three months.
Financial Performance and Market Capitalization
Anavex Life Sciences Corporation (AVXL) has experienced a quarterly rise of 47.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 644.45M and boasts a workforce of 40 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.47, with a change in price of +1.77. Similarly, Anavex Life Sciences Corporation recorded 1,077,325 in trading volume during the last 100 days, posting a change of +30.36%.
AVXL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AVXL stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
AVXL Stock Stochastic Average
As of today, the raw stochastic average of Anavex Life Sciences Corporation over the past 50 days is 47.42%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 12.84%. Additionally, the Stochastic %K and %D values for the company were 41.79% and 56.54%, respectively, over the past 20 days.
AVXL Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -18.37%. However, over the last six months, the performance has been weaker by 88.59%. The price of AVXL decreased -1.30% over the last 30 days. And in the last five days, it has fallen by -15.84%.
